Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey

Gregory Y. H. Lip*, Nikolaos Dagres, Alessandro Proclemer, Jesper Hastrup Svendsen, Laurent Pison, Carina Blomstrom-Lundqvist

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for stroke prevention in atrial fibrillation (AF) among members of the European Heart Rhythm Association research network. The average number of performed LAAO was 10.6 per year and most (73) centres performed 10 procedures per year. We found that LAAO was being performed for stroke prevention in AF, for the most common indication being othe patient has absolute contraindication to long term oral anticoagulants'. Among survey respondents, LAAO procedures are most often performed by interventional cardiologists. Experience varied widely, and this was reflected in the wide range of thromboembolic and procedural (tamponade, bleeding) complications reported by the respondents to this EP wire survey.
Original languageEnglish
Pages (from-to)141-143
JournalEP Europace
Issue number1
Publication statusPublished - Jan 2013


  • Anticoagulation
  • Atrial fibrillation
  • Left atrial appendage occlusion
  • Stroke

Cite this